myelosuppression love



from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A reduction of bone marrow activity that leads to a lower concentration of platelets, red blood cells and white blood cells


Sorry, no etymologies found.


  • The FDA said major side effects for both included nerve damage, infections, reactions from the infusion and myelosuppression, a common side effect from chemotherapy that causes decreased blood cell production.

    Yahoo! News: Business - Opinion

  • Other prominent side-effects of this drug class include myelosuppression (low blood counts) and peripheral neuropathy (disabling nerve damage).


  • Six patients had fatal events associated with their underlying disease and myelosuppression (anemia, neutropenia, and thrombocytopenia) that were considered at least possibly related to drug treatment. Aktuelle Nachrichten

  • Rarely, myelosuppression, thrombo-cytopenia, and leukopenia have been reported in patients taking colchicine.

    Medlogs - Recent stories

  • The proposed novel mechanism of action, non-cross resistance with chemotherapeutic agents currently used in the clinic, and lack of CPI-613-related myelosuppression in humans to date, make CPI-613 a suitable candidate for clinical evaluation in these types of cancers.

    RedOrbit News - Technology

  • Six patients had fatal events associated with their underlying disease and myelosuppression

    The Earth Times Online Newspaper

  • IMGN901 was found to be well tolerated, with no clinically significant myelosuppression.

    ImmunoGen, Inc. Announces Presentation of Positive Initial Clinical Data for IMGN901 Used in a Combination Regimen for Multiple Myeloma - Yahoo! Finance

  • (Abstract #3762) Dr. Manevich is presenting data illustrating that modulation of cell surface redox status and transmembrane potential by NOV-002 in myeloid cells induces changes in calcium influx and subsequent NO generation which may be relevant to enhanced recovery from chemotherapy-induced myelosuppression seen in clinical studies of this drug candidate. Digital 50 Daily Industry News RSS Feed

  • • This inappropriate ratio and the frequently observed strong myelosuppression were the reasons for abandoning phosphorus-32.

    Recently Uploaded Slideshows

  • IMGN901 was found to be generally well tolerated and was not associated with significant myelosuppression or other side effects that would limit its ability to be administered in combination with other active agents.

    Health News from Medical News Today


Log in or sign up to get involved in the conversation. It's quick and easy.